300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Mobile
Retail
Oil and Gas
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Software
Facebook
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Nepal
Pakistan
Russian Federation
Turkey
Mexico
Liberia
Tajikistan
Sweden
Romania
Zambia
Oman
Poland
Puerto Rico
Colombia
Guernsey
Cameroon
China
Armenia
Costa Rica
Côte d'Ivoire
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Nicaragua
Panama
Serbia
Morocco
Uzbekistan
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
New Zealand
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uruguay
Uganda
Seychelles
Moldova
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Sierra Leone
Portugal
El Salvador
Senegal
Germany
India
Canada
Ireland
Kenya
Saudi Arabia
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Albania
Asia
Spain
Bangladesh
Angola
Europe
Barbados
Belgium
Austria
Ethiopia
Cyprus
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Qatar
Jersey
Estonia
Belize
Bolivia
Belarus
Finland
Algeria
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Liechtenstein
Iceland
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Guanghua Wutong Fund

VC Fund

Guanghua Wutong Fund is an investment fund.

Total investments:
14
Last investment:
Lead investor:
7%

Last updated:

Industries Guanghua Wutong Fund invests in

MedicalHealth CareMedical DeviceBiotechnologyPharmaceutical

Stages Guanghua Wutong Fund invests in

Series BSeries AVenture - Series UnknownSeedDebt Financing

Countries Guanghua Wutong Fund invests in

ChinaUnited States

Contacts

NameEmailPhoneSocials
Deng Yixin
Xiang Wentian

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 5 (36%)
  • Health Care 5 (36%)
  • Medical Device 4 (29%)
  • Biotechnology 3 (21%)
  • Pharmaceutical 2 (14%)
See all 11 industries →

Stage

  • Series B 6 (43%)
  • Series A 4 (29%)
  • Venture - Series Unknown 2 (14%)
  • Seed 1 (7%)
  • Debt Financing 1 (7%)

Country

  • China 10 (71%)
  • United States 1 (7%)

Team

NameTitleInvestmentsLinksEmail
Deng Yixin Vice President
Vice President Total investments: 1 Find email
Xiang Wentian Managing Director
Managing Director Total investments: 4 Find email

Investments

CompanyDescriptionRoundLinks
Tianneng Jingxiu
Tianneng Jingxiu is an AI-powered bio-breeding platform provider that focuses on providing comprehensive technical solutions for the innovation and creation of crop seeds, primarily engaged in the development of intelligent nuclear sterile seed production technology for maize. Series A / Jul 13, 2026
Hengyu Medical Hengyu Medical
Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment. $14.1M / Venture - Series Unknown / Dec 08, 2025
Brise Pharma Brise Pharma
Brise Pharma operates in the scientific research and technical service industry. $28.1M / Series A / Nov 11, 2025
Suzhou Meichuang Suzhou Meichuang
Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance $27.8M / Series B / Jun 13, 2025
RootPath RootPath
RootPath is a Cambridge-based biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine and cancer immunotherapy. Their next generation technologies allow us to precisely monitor, modulate and steer the immune system for a revolution in the diagnosis and treatment of cancer. $1.4M / Venture - Series Unknown / Apr 24, 2025
Strongest Laser Strongest Laser
Strongest Laser is a high-power fiber laser equipment developer. Series B / Mar 31, 2025
Rona Therapeutics Rona Therapeutics
Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines. $25M / Series B / Mar 14, 2025
Hexaell Biotech Hexaell Biotech
Hexaell Biotechnology Co., Ltd is a start-up company pioneering in stem cell and artificial organ. The disruptive technologies were original published in "Nature. 475(7356):386-9" and "Cell Stem Cell. 14(3):370-84" from Chinese Academy of Sciences. Hexaell Biotechnology had licensed iHep and HiHep technologies from ChineseAcademy of Sciences and developed medical devices of bio-artificial liver to replace liver function of human and cure liver failure diseases. Hexaell has finished pilot clinical studies in 6 liver failure patients in leading hepatopathy centers in China. $27.4M / Series B / Feb 08, 2025
C Ray Therapeutics
C Ray Therapeutics develops healthcare advancements through nuclear medicine. It was founded in 2020. $100M / Series A / Nov 16, 2024
Qinglan Jichuang Qinglan Jichuang
Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise. Seed / Oct 28, 2024
See all 14 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Mobile
Retail
Oil and Gas
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Software
Facebook
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Nepal
Pakistan
Russian Federation
Turkey
Mexico
Liberia
Tajikistan
Sweden
Romania
Zambia
Oman
Poland
Puerto Rico
Colombia
Guernsey
Cameroon
China
Armenia
Costa Rica
Côte d'Ivoire
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Nicaragua
Panama
Serbia
Morocco
Uzbekistan
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
New Zealand
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uruguay
Uganda
Seychelles
Moldova
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Sierra Leone
Portugal
El Salvador
Senegal
Germany
India
Canada
Ireland
Kenya
Saudi Arabia
Latvia
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Albania
Asia
Spain
Bangladesh
Angola
Europe
Barbados
Belgium
Austria
Ethiopia
Cyprus
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Qatar
Jersey
Estonia
Belize
Bolivia
Belarus
Finland
Algeria
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Liechtenstein
Iceland
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Guanghua Wutong Fund invest in?

Guanghua Wutong Fund invests primarily in Medical, Health Care and Medical Device startups, most often at Series B and Series A stage. Most of the 14 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Guanghua Wutong Fund?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Guanghua Wutong Fund?

The team at Guanghua Wutong Fund includes Deng Yixin (Vice President) and Xiang Wentian (Managing Director). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Guanghua Wutong Fund Find emails